Brief: Novozymes Maintains FY Organic Sales Growth Outlook

Novozymes A/S

26/10/2023 07:12

Oct 26 (Reuters) - Novozymes A/S  NZYMb.CO :
    * INTERIM REPORT FOR 9M 2023
    * FULL-YEAR ORGANIC SALES GROWTH OUTLOOK MAINTAINED AT 4-6%.
    * PRICING IS EXPECTED TO BE THE MAIN DRIVER OF ORGANIC 
GROWTH
    * OUTLOOK FOR EBIT MARGIN B.S.I. AND ROIC INCL. GOODWILL
B.S.I.
MAINTAINED
    * GROWTH SUPPORTED BY DESTOCKING GRADUALLY LEVELLING OFF IN
THE
FOOD-RELATED AREAS, INCREASING  CUSTOMER DEMAND FOR SUSTAINABLE
BIOSOLUTIONS
    * THIRD QUARTER NET PROFIT SUPPORTED BY INTEREST INCOME FROM
THE
SETTLEMENT OF A LONG-STANDING TAX CASE

Source text for Eikon:  ID:nGNE8TNKHJ 
Further company coverage:  NZYMb.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))